Clinical Trials Logo

Filter by:
NCT ID: NCT03030638 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

Drug Utilization Study for Olodaterol

Start date: February 8, 2017
Phase:
Study type: Observational

This study aims to characterise the use of single-agent olodaterol and single-agent indacaterol, the only marketed long-acting beta2-agonist (LABA)s authorised for chronic obstructive pulmonary disease (COPD), but not for asthma, in clinical practice.

NCT ID: NCT03027687 Completed - Addiction Clinical Trials

Effects of Repetitive tDCS on ad Libitum Smoking Behavior: EMA and EEG Study

Start date: October 2016
Phase: N/A
Study type: Interventional

Bilateral (left cathodal/ right anodal) transcranial Direct Current Stimulation (tDCS) over the dorsolateral prefrontal cortex (DLPFC) seems to reduce craving and to increase the time till smoking the first cigarette after the intervention. The current study explores whether actual cigarette consumption decreases after repetitive tDCS. Cigarette consumption and craving will therefore be measured by means of EMA, before (at baseline), during and after multiple tDCS sessions, and at 3 months follow-up. To study the working mechanism behind the effects of tDCS, electrophysiological responses (ERPs) and behavioral measures of cognitive control functioning will be taken into account at baseline, one day after the last tDCS session and at three months follow up. We hypothesize that cigarette consumption will decrease after repetitive tDCS, and that this effect is associated with better cognitive control functioning.

NCT ID: NCT03026946 Recruiting - Hand Eczema Clinical Trials

Alitretinoin vs Cyclosporine in Severe Recurrent Vesicular Hand Eczema

ALICsA
Start date: May 29, 2017
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the efficacy of alitretinoin and cyclosporine in the treatment of patients with severe recurrent vesicular hand eczema.

NCT ID: NCT03026907 Recruiting - Hand Eczema Clinical Trials

Alitretinoin vs Azathioprine in Severe Non-hyperkeratotic Hand Eczema

ALIAZ
Start date: May 2016
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the efficacy of alitretinoin and azathioprine in the treatment of patients with severe chronic non-hyperkeratotic hand eczema.

NCT ID: NCT03026829 Terminated - Clinical trials for Tinnitus, Hearing Loss, Cochlear Implant Users

Sound Therapy for Tinnitus Relief in Cochlear Implant Users

Start date: October 3, 2017
Phase: N/A
Study type: Interventional

The aim of this exploratory study is to evaluate the use and effectiveness of sound therapy for tinnitus relief in cochlear implant users with tinnitus. The sound therapy is a combination of tinnitus counselling and sound enrichment with the Cochlear Active Relief from Tinnitus (CART) firmware.

NCT ID: NCT03026244 Completed - Inflammation Clinical Trials

Effect of Milk Protein and Prebiotics in Combination With Vitamin D on Innate Immunity in Elderly People

Start date: November 2016
Phase: N/A
Study type: Interventional

Rationale: The immune system in the ageing population becomes compromised with age (termed "Immunosenescence"). Therefore, elderly people have a decreased ability to respond to infection and vaccination. Furthermore, many of the health issues associated with ageing are linked to inflammation ("Inflammaging"). It has been suggested that this compromised immune function is in part due to reduced Toll-like receptor (TLR) function, which is part of the innate immune system. Milk and dairy based products have been shown to have beneficial effects on inflammation and immunity. This effect may be mediated via support of the innate immune response and promotes TLR7 signaling in in vitro assays (unpublished observation). Also prebiotics have been suggested to influence markers of innate immune function. Furthermore, TLR function has been suggested to be correlated to vitamin D status. Therefore, in the current pilot study, the potential of milk protein, prebiotics and vitamin D to support innate immune function in elderly will be investigated. Objective: Aim of the current study is to evaluate the effect of milk protein on the innate immune response in elderly in a pilot study. Furthermore, support of this effect by prebiotics and Vitamin D will be studied. Study design: The study will be a double-blind placebo-controlled pilot study. Study population: Healthy female elderly subjects of 65-85 years of age. Intervention: Period 1: Milk protein or placebo. Period 2: Milk protein + prebiotics or placebo. Period 3: Milk protein + prebiotics + Vitamin D or placebo.

NCT ID: NCT03026140 Recruiting - Colon Carcinoma Clinical Trials

Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancer

NICHE
Start date: March 29, 2017
Phase: Phase 2
Study type: Interventional

In this exploratory study, patients with stage 1-3 adenocarcinoma of the colon with no signs of distant metastases will be treated with short-term immunotherapy + novel IO combinations (i.e. anti-IL 8, COX2-inhibitors). This treatment will be given during the window period until surgical resection of the tumor. The duration of treatment will be approximately 6 weeks.

NCT ID: NCT03026075 Completed - CRC Clinical Trials

Evaluation of the Performance of the Motus Cleansing System (MCS)

MCS
Start date: December 22, 2016
Phase: N/A
Study type: Interventional

The study is multi-center study ,planned as a single arm, open trial, aimed at evaluating the performance and safety of a colon cleansing device during a colonoscopy procedure in a poorly prepared colons.

NCT ID: NCT03026049 Terminated - Clinical trials for Randomized Clinical Trial

Stent Versus Conservative Treatment in Patients With Deep Venous Obstruction

STEVECO
Start date: March 9, 2017
Phase: N/A
Study type: Interventional

Patients will be randomised between deep venous stenting or conservative management

NCT ID: NCT03025997 Completed - Appetite Regulation Clinical Trials

Lipid Encapsulation for Ileal Brake Activation

Start date: January 24, 2017
Phase: N/A
Study type: Interventional

This study evaluates the ability of encapsulation of orally applied lipids in a yoghurt snack to modify ad libitum food intake and satiety, without GI symptoms. Every subject receives two treatments (active, and placebo) on two different days, following a randomized cross-over design.